Magnetic resonance enterography as a predictor of disabling disease in newly diagnosed Crohn's Disease

niversity College London0 个研究点目标入组 198 人2019年3月12日

概览

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36192092/ (added 04/10/2022)

注册库

who.int

开始日期

2019年3月12日

结束日期

2022年12月31日

最后更新

3年前

研究类型

Observational

性别

All

发起方

niversity College London

•METRIC cohort:
•1\. Enrolled in the METRIC study, new diagnosis cohort AND
•2\. Formed part of the final new diagnosis cohort (i.e. with a confirmed diagnosis of Crohn's disease and underwent relevant study interventions and follow\-up). METRIC new diagnosis cohort inclusion criteria were:
•2\.1\. Aged 16 years or more
•2\.2\. Newly diagnosed with Crohn's disease based on endoscopic, histological, clinical and radiological findings, OR
•2\.3\. Highly suspected of Crohn's disease based on characteristic endoscopic, imaging and/or histological features but pending final diagnosis (only participants who ultimately were confirmed to have Crohn's disease will continue in this extension study) AND
•3\. Have given signed consent to be part of METRIC\-EF
•Retrospective cohort:
•1\. Aged 16 years or more and received a new diagnosis of Crohn's disease based on endoscopic, histological, clinical and radiological findings
•2\. Dedicated enteric imaging (either MRE or SBUS) acquired according to the standards of the METRIC study and performed either \< 3 months after, or \< 3 months prior to the new diagnosis of Crohn's disease